Abstract: Motor vehicle comprising a drive system arranged in a compartment at the front of a vehicle, a cradle (2) comprising a platform (4) fastened in this compartment in the region of a floor of the vehicle, an anti-roll bar (10) fastened in the vertical direction above the platform (4), and an impact device (30) fastened to a front edge (20) of the platform (4), behind an impact block fastened to a powertrain of this vehicle, in order, in the event of a recoil of this powertrain, to allow the impact block to bear on the impact device (30), which deforms, the impact device (30) comprising an upper part projecting above the platform (4), which, in the event of a large deformation, bears on the anti-roll bar (10).

Abstract: In one example, a trigger is obtained for a dynamic ideogram to dynamically interact with the electronic messaging environment. In response to the trigger, it is determined how the dynamic ideogram is to dynamically interact with the electronic messaging environment including performing an analysis of the electronic messaging environment. Based on the analysis of the electronic messaging environment, instructions to render the dynamic ideogram to dynamically interact with the electronic messaging environment are generated for a first user device configured to communicate with a second user device via the electronic messaging environment.

Abstract: The invention relates to the field of parasitology. Methods and peptidic substrate for screening and identifying inhibitors of Plasmodium are described. Also described are compounds identified by these screening methods, including more particularly inhibitors of Plasmodium subtilisin-like proteases. The invention also concerns anti-malaria compounds, anti-malaria compositions, and uses thereof for preventing, treating, improving, and/or alleviating a Plasmodium infection in a subject, and more Plasmodium vivax and/or by Plasmodium falciparum human infections.

Abstract: The invention relates to the field of parasitology. Methods and peptidic substrate for screening and identifying inhibitors of Plasmodium are described. Also described are compounds identified by these screening methods, including more particularly inhibitors of Plasmodium subtilisin-like proteases. The invention also concerns anti-malaria compounds, anti-malaria compositions, and uses thereof for preventing, treating, improving, and/or alleviating a Plasmodium infection in a subject, and more Plasmodium vivax and/or by Plasmodium falciparum human infections.

Abstract: A device (1) for providing protection for an electrical installation against overvoltages including at least one protection component (2), the device having a first mounting (14) delimiting a first interstitial space (14?) with a dimension fixed by construction that at least partially houses a first conducting element (10) and a second conducting element (11) to make the electrical connection between the first conducting element and the second conducting element, the device also having a second mounting (15) delimiting a second interstitial space (15?) with a dimension fixed by construction that at least partially houses a third conducting element (12) and a fourth conducting element (13) so as to make the electrical connection between the third conducting element and the fourth conducting element.

Abstract: The present invention relates to novel pharmaceutical aerosol formulations comprising: (A) a therapeutic agent in the form of particles coated by at least one coating excipient and at least one surfactant, in suspension in (B) a liquefied propellant gas for the administration of therapeutic agents particularly by the pulmonary route and to process for preparing these formulations. It also relates to novel particles suitable for use in such formulations.

Abstract: The stator shroud is made up of components (2) juxtaposed so as to form circumferences, which are successive and assembled separately to a common housing which surrounds them. Characteristically, the assembly is made with only one single fixing point (7) per component (2), while being completed by a support point (21) sliding along the circumference. The result is a more flexible component assembly and a more even distortion, which allows better control of the clearances between the shroud and the rotor blades it surrounds.

Abstract: The bearing block (20) is intended to support a mechanical transmission member comprising a rolling bearing (12). It comprises a fixing sole (22) and forms a bore (26) for supporting the rolling bearing, roughly coaxial with the rolling bearing, and a member (50) for clamping the bearing block onto the rolling bearing. The bore is formed by a clamping jaw (28) of one piece which on its periphery has a single open location (A).

Abstract: The present invention relates to novel pharmaceutical aerosol formulations comprising: (A) a therapeutic agent in the form of particles coated by at least one coating excipient and at least one surfactant, in suspension in (B) a liquefied propellant gas for the administration of therapeutic agents particularly by the pulmonary route and to process for preparing these formulations. It also relates to novel particles suitable for use in such formulations.

Abstract: It has been unexpectedly determined that isoprene-butadiene rubber having a high glass transition temperature within the range of about −40° C. to about −25° C. (high Tg IBR) can be loaded with silica as a filler and utilized in manufacturing tire treads that have outstanding performance characteristics. For instance, such tire treads offer lower hysteresis at high temperatures (improved rolling resistance) and higher hysteresis at low temperatures (improved wet traction characteristics). By utilizing high Tg IBR in tire tread compounds, the maximum benefits of silica compounding can be realized without the need for solution or emulsion styrene-butadiene rubber (SBR) in the tread rubber formulations. The tire tread rubber formulations of this invention will normally contain about 20 phr (parts per 100 parts of rubber) to about 100 phr of the high Tg IBR.

Abstract: This invention relates to a tire with a rubber tread reinforced with silica and containing one or more additives designed to aid ice traction for the tread. Such additive is selected from at least one of (i) at least one organic fiber having hydroxyl groups on the surface thereof selected from cellulose fibers and wood fibers and (ii) small, hollow, spherical ceramic particles having silanol groups on the surface thereof. The rubber is composed of at least one or more diene-based sulfur vulcanizable elastomers having a Tg of less than -30.degree. C. and containing silica as predominant particulate reinforcement and other traditional rubber compound ingredients. In particular, a coupler is used to couple the silica as well as the said additive(s) to the elastomer(s) in the tire tread composition.

Abstract: A pharmaceutical dosage unit defined by a sheath composed of a bioadhesive material which surrounds one or more capsules and one or more nonliquid supports containing the active pharmaceutical ingredient. The capsules are made of a mixture of approximately 70% gelatin and 30% glycerin. The supports can be tablets. The dosage unit is useful in providing a sustained release effect of the pharmaceutical ingredient in the lower part of the rectum for a period of 24 hours.

Abstract: A water survival device has an inflatable liferaft and a pressurized gas bottle packed in a container. The container has a first waterproof compartment containing the liferaft and a second waterproof compartment containing the pressurized gas bottle. The first and second waterproof compartments are separated by a substantially planar rigid watertight partition. The second waterproof compartment can be opened without opening the first waterproof compartment so that it is possible to inspect the pressurized gas bottle without opening the first waterproof compartment.